Evidence map›Paper›PMID 21693707›Full record

ArticleThe Journal of biological chemistry2011

Pivotal role for alpha1-antichymotrypsin in skin repair.

Daniel C Hoffmann, Christine Textoris, Felix Oehme, Tobias Klaassen, Andreas Goppelt, Axel Römer, Burkhard Fugmann, Jeffrey M Davidson, Sabine Werner, Thomas Krieg and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. mSphere · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Daniel C HoffmannDepartment of Dermatology, University of Cologne, 50931 Cologne, Germany.
Christine TextorisDepartment of Dermatology, University of Cologne, 50931 Cologne, Germany.
Felix OehmeBiotech Development, Bayer HealthCare AG, 42117 Wuppertal, Germany.
Tobias KlaassenA&M Labor GmbH, 50126 Bergheim, Germany.
Andreas GoppeltBaxter Innovation GmbH, 1020 Vienna, Austria.
Axel RömerA&M Labor GmbH, 50126 Bergheim, Germany.
Burkhard FugmannBayer Innovation GmbH, 40225 Düsseldorf, Germany.
Jeffrey M DavidsonResearch Service, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee 37212,; Vanderbilt University School of Medicine, Nashville, Tennessee 37240.
Sabine WernerETH Zurich, Honggerberg, 8092 Zurich, Switzerland, and.
Thomas KriegDepartment of Dermatology, University of Cologne, 50931 Cologne, Germany,; Center for Molecular Medicine Cologne, University of Cologne, 50674 Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases, University of Cologne, 50674 Cologne, Germany.
Sabine A EmingDepartment of Dermatology, University of Cologne, 50931 Cologne, Germany,; Center for Molecular Medicine Cologne, University of Cologne, 50674 Cologne, Germany; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases, University of Cologne, 50674 Cologne, Germany. Electronic address: sabine.eming@uni-koeln.de.
Bayer (Germany) · DECologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEUniversity of Cologne · DEBaxter (Austria) · ATETH Zurich · CHVA Tennessee Valley Healthcare System · US

Funding

ELASTIN AND COLLAGEN IN THE AGING PROCESSR01AG006528 · NIA · VANDERBILT UNIVERSITY · PI DAVIDSON, JEFFREY M. · 1986 to 2011
$2.9M
NIA NIH HHS R01 AG006528
6 · The paper itself

Abstract

α1-Antichymotrypsin (α1-ACT) is a specific inhibitor of leukocyte-derived chymotrypsin-like proteases with largely unknown functions in tissue repair. By examining human and murine skin wounds, we showed that following mechanical injury the physiological repair response is associated with an acute phase response of α1-ACT and the mouse homologue Spi-2, respectively. In both species, attenuated α1-ACT/Spi-2 activity and gene expression at the local wound site was associated with severe wound healing defects. Topical application of recombinant α1-ACT to wounds of diabetic mice rescued the impaired healing phenotype. LC-MS analysis of α1-ACT cleavage fragments identified a novel cleavage site within the reactive center loop and showed that neutrophil elastase was the predominant protease involved in unusual α1-ACT cleavage and inactivation in nonhealing human wounds. These results reveal critical functions for locally acting α1-ACT in the acute phase response following skin injury, provide mechanistic insight into its function during the repair response, and raise novel perspectives for its potential therapeutic value in inflammation-mediated tissue damage.

Indexed as

AnimalsHumansIntracellular Signaling Peptides and ProteinsLeukocyte ElastaseMicePeptidesSerpinsSkinWound HealingIntracellular Signaling Peptides and Proteinslambda Spi-2Leukocyte ElastasePeptidesSERPINA3 protein, humanSerpins

Identifiers

PMID21693707
PMCPMC3190696
OpenAlexW1986410103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.